Journey to a Tobacco-free Certified Community Behavioral Health Clinic (CCBHC): A Conversation, co-hosted with NBHN
CEO, Preferred Behavioral Health Group
Mary Pat Angelini is CEO of Preferred Behavioral Health Group since 2013. Prior to her current role at PBHG, she served as Executive Director of Prevention First since 1992. Both non-profits have been the recipient of many awards under her leadership. Mary Pat served in NJ’s General Assembly from 2008-2016 as Deputy Conference Leader and ranking member of the Assembly Health and Senior Services Committee as well as the Assembly Human Services Committee. While in the Legislature, Ms. Angelini sponsored legislation to improve the conditions at state psychiatric hospitals, and to address underage drinking and drug abuse. Mary Pat has received numerous awards over her career including NJAMHAA’s “Legislative Champion for Improving Treatment” and was chosen by the Mental Health Association of Monmouth County to receive the “Tony Dowling Child Advocacy” Award. Most recently she was named by NJBIZ as “Best 50 Women in Business”. Mary Pat earned a Bachelor of Social Welfare from East Tennessee State University and a Master of Public Administration from Fairleigh Dickinson University. She is a Certified Prevention Specialist.
Chief Medical Officer at Pittsburgh Mercy Health System
Jack Todd Wahrenberger is a Family Practice physician who works in Pittsburgh, Pa. as the Chief Medical Officer at the Pittsburgh Mercy Health System. He studied Medicine and Public Health at the University Of Pittsburgh School of Medicine where he obtained an MD and MPH degree. Dr. Wahrenberger co-founded the North Side Christian Health Center, a Federally Qualified Health Center that serves uninsured and underserved persons in the inner city of Pittsburgh. He served as the Medical Director of this FQHC for 16 years. In 2012, Dr. Wahrenberger joined Pittsburgh Mercy Health System to start a fully integrated primary care clinic that serves as the medical and mental health home for over 5,000 individuals as part of SAMHSA’s PBHCI grant program. In 2017, Dr. Wahrenberger became the Chief Medical Officer and oversees a medical staff consisting of 15 Psychiatrist, 8 CRNP’s and 5 Primary Care Providers. Pittsburgh Mercy is a Certified Community Behavioral Health Clinic, which provides a wide array of services including 4 ACT teams, a crisis center, partial hospitalization programs, adult, child and adolescent outpatient mental health, outpatient primary care, street medicine, as well as services for those with intellectual disabilities. Dr. Wahrenberger also serves on the Medical Director Institute at the National Council for Behavioral Health.
Project Director Practice Improvement and Consulting at the National Council for Mental Wellbeing
Clement Nsiah, Ph.D., M.S., is the Director of the CCBHC-E National Training and Technical Assistance Center. He joined the National Council from BestSelf Behavioral Health where he led the agency’s Population Health and Evaluation team. At BestSelf, Dr. Nsiah oversaw the agency’s population health initiatives and projects implemented to improve the health outcomes of patients who visited the agency’s community-based clubhouses and clinics. Dr. Nsiah also served as a member and advisor to the agency’s Quality Improvement department. Over the years, Dr. Nsiah’s primary focus has been on leading the execution and performance monitoring of population health strategies and clinical priorities. He has partnered with healthcare leaders to improve health outcomes and contribute to sustainable medical cost trends through access to safe and effective healthcare. Throughout his career, Dr. Nsiah has authored several manuscripts and continues to focus on his doctoral research study of health insurance's impact on successful tobacco cessation outcomes.
Project Manager, Practice Improvement and Consulting at the National Council for Mental Wellbeing
Hope Rothenberg currently serves as Project Manager, Practice Improvement and Consulting at the National Council for Mental Wellbeing. In this role, Hope leads project activities for CDC-funded initiatives including the National Behavioral Health Network for Tobacco & Cancer Control (NBHN) which is 1 of 8 CDC National Networks committed to eliminating tobacco and cancer-related disparities and advancing health equity. In 2019, she graduated magna cum laude from the George Washington University with a Bachelor of Science (BS) in Public Health and a major in psychology. Prior to her role at the National Council, she served as the Coordinator of Education at the Association for Healthcare Philanthropy, where she provided technical assistance to international healthcare philanthropists. Hope has extensive experience in event coordination and project management and is passionate about improving access to and quality of mental health and substance use treatment services.
- Describe the continuum of comprehensive tobacco control efforts in CCBHCs
- Explain the three reasons for tobacco–free Certified Community Behavioral Health Clinics (CCBHCs)
- Identify two insights and strategies to implement tobacco–free policies
CME/CE credit is available for the recorded version of this webinar. Scroll down and click on the "Get Credit" button to begin.
The University of California, San Francisco (UCSF) School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
UCSF designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the webinar activity.
Advance Practice Registered Nurses and Registered Nurses: For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 CreditTM issued by organizations accredited by the ACCME.
Physician Assistants: The National Commission on Certification of Physician Assistants (NCCPA) states that the AMA PRA Category 1 CreditTM are acceptable for continuing medical education requirements for recertification.
California Pharmacists: The California Board of Pharmacy accepts as continuing professional education those courses that meet the standard of relevance to pharmacy practice and have been approved for AMA PRA category 1 CreditTM. If you are a pharmacist in another state, you should check with your state board for approval of this credit.
California Psychologists: The California Board of Psychology recognizes and accepts for continuing education credit courses that are provided by entities approved by the Accreditation Council for Continuing Medical Education (ACCME). AMA PRA Category 1 CreditTM is acceptable to meeting the CE requirements for the California Board of Psychology. Providers in other states should check with their state boards for acceptance of CME credit.
California Behavioral Science Professionals: University of California, San Francisco School of Medicine (UCSF) is approved by the California Association of Marriage and Family Therapists to sponsor continuing education for behavioral health providers. UCSF maintains responsibility for this program/course and its content.
Course meets the qualifications for 1.0 hour of continuing education credit for LMFTs, LCSWs, LPCCs, and/or LEPs as required by the California Board of Behavioral Sciences. Provider # 64239.
ACCREDITATION FOR CALIFORNIA ADDICTION COUNSELORS
The UCSF office of continuing medical education is accredited by the California Consortium of Addiction Programs and Professionals (CCAPP), to provide continuing education credit for California addiction counselors. UCSF designates this live, virtual activity, for a maximum of 1.0 CCAPP credit. Addiction counselors should claim only the credit commensurate with the extent of their participation in the activity. Provider number: 7-20-322-0722.
This UCSF CME activity was planned and developed to uphold academic standards to ensure balance, independence, objectivity, and scientific rigor; adhere to requirements to protect health information under the Health Insurance Portability and Accountability Act of 1996 (HIPAA); and include a mechanism to inform learners when unapproved or unlabeled uses of therapeutic products or agents are discussed or referenced.
All speakers, planning committee members and reviewers have disclosed they have no relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Mary Pat Angelini, MPA, Anita Browning, Christine Cheng, Brian Clark, Pamela Ling, MD, MPH, Jennifer Matekuare, Clement Nsiah, PhD, MS, Ma Krisanta Pamatmat, MPH, Hope Rothenberg, Catherine Bonniot Saucedo, Jack Todd Wahrenberger, MD, MPH, and Aria Yow, MA.